These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25724823)

  • 1. The effects of reduced copayments on discontinuation and adherence failure to statin medication in Australia.
    Knott RJ; Petrie DJ; Heeley EL; Chalmers JP; Clarke PM
    Health Policy; 2015 May; 119(5):620-7. PubMed ID: 25724823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins.
    McRae I; van Gool K; Hall J; Yen L
    Appl Health Econ Health Policy; 2017 Oct; 15(5):625-634. PubMed ID: 28660496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.
    Helin-Salmivaara A; Korhonen MJ; Alanen T; Huupponen R
    J Clin Pharm Ther; 2012 Feb; 37(1):58-64. PubMed ID: 21410736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia.
    Seaman KL; Sanfilippo FM; Roughead EE; Bulsara MK; Kemp-Casey A; Bulsara C; Watts GF; Preen D
    BMJ Open; 2017 Jun; 7(6):e013691. PubMed ID: 28637723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.
    Ofori-Asenso R; Ilomäki J; Tacey M; Si S; Curtis AJ; Zomer E; Bell JS; Zoungas S; Liew D
    Br J Clin Pharmacol; 2019 Jan; 85(1):227-235. PubMed ID: 30402916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase.
    Seaman KL; Sanfilippo FM; Bulsara MK; Brett T; Kemp-Casey A; Roughead EE; Bulsara C; Preen DB
    Aust Health Rev; 2020 Jun; 44(3):377-384. PubMed ID: 32389176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
    Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X; Gross CR; Schommer J; Cline R; St Peter WL
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.
    Ellis JJ; Erickson SR; Stevenson JG; Bernstein SJ; Stiles RA; Fendrick AM
    J Gen Intern Med; 2004 Jun; 19(6):638-45. PubMed ID: 15209602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands.
    Alfian SD; Worawutputtapong P; Schuiling-Veninga CCM; van der Schans J; Bos JHJ; Hak E; Denig P
    Curr Med Res Opin; 2018 Jun; 34(6):1013-1019. PubMed ID: 29292657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the use of functional foods enriched with phytosterols/-stanols on adherence to statin therapy.
    Eussen SR; Bouvy ML; Rompelberg CJ; van der Elst ME; Garssen J; Oosterveld MH; de Boer A; de Gier JJ; van Kranen HJ; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):830-7. PubMed ID: 21648012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of copayment and statin adherence stratified by socioeconomic status.
    Kazerooni R; Bounthavong M; Watanabe JH
    Ann Pharmacother; 2013 Nov; 47(11):1463-70. PubMed ID: 24259605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme.
    Thai LP; Moss JR; Godman B; Vitry AI
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):419-33. PubMed ID: 26707482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
    Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
    Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of statin use among older adults: A nationwide cross-sectional study.
    Ofori-Asenso R; Ilomäki J; Tacey M; Zomer E; Curtis AJ; Bell JS; Zoungas S; Liew D
    J Clin Lipidol; 2019; 13(1):156-162.e1. PubMed ID: 30446321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of statin copayments on adherence and medical care utilization and expenditures.
    Gibson TB; Mark TL; Axelsen K; Baser O; Rublee DA; McGuigan KA
    Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a public media event on the use of statins in the French population.
    Bezin J; Francis F; Nguyen NV; Robinson P; Blin P; Fourrier-Réglat A; Pariente A; Moore N
    Arch Cardiovasc Dis; 2017 Feb; 110(2):91-98. PubMed ID: 27473579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.